Concept
Patient Access
10 Cancer Treatment Approvals From September 2026 and What They Mean for You | CURE / 3. A Shorter Hospital Stay for Imdelltra
"What it means for you: Less time in the hospital could make Imdelltra easier to start, especially for people who live far from a cancer center. When the drug was first approved in 2024, Dr. Roy Herbst of Yale Cancer Center told CURE, \"This accelerated approval of Imdelltra really is something that is great for patients,\" noting how few options people with small cell lung cancer had. Read more in Imdelltra for Small Cell Lung Cancer Addresses Key Unmet Needs."
Related Ideas
- Treatment Access10 Cancer Treatment Approvals From September 2026 and What They Mean for You | CURE · Key Takeaways
- September Options10 Cancer Treatment Approvals From September 2026 and What They Mean for You | CURE · Key Takeaways
- Treatment Options10 Cancer Treatment Approvals From September 2026 and What They Mean for You | CURE · 7. Inluriyo Plus Verzenio for ESR1-Mutated Breast Cancer
- Treatment Access10 Cancer Treatment Approvals From September 2026 and What They Mean for You | CURE · 8. Bravnetsa for Neuroendocrine Tumors
- Treatment Access10 Cancer Treatment Approvals From September 2026 and What They Mean for You | CURE · 6. Bexlutry for Neuroendocrine Tumors
- Approval10 Cancer Treatment Approvals From September 2026 and What They Mean for You | CURE · 2. Hyrnuo as a First Treatment for HER2-Mutant Lung Cancer
- Nonsurgical Option10 Cancer Treatment Approvals From September 2026 and What They Mean for You | CURE · 4. Ameluz Light Therapy for a Common Skin Cancer
- Testing10 Cancer Treatment Approvals From September 2026 and What They Mean for You | CURE · 2. Hyrnuo as a First Treatment for HER2-Mutant Lung Cancer